搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
1 小时
Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Intera ...
5 分钟
Boston Scientific To Buy Intera Oncology For Undisclosed Terms
Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire Intera Oncology Inc., a ...
Nursing Times
2 小时
More action needed to reduce IV injuries, urges nurse
Find out why a nurse leader is calling for better awareness on the risks of infiltration and extravasation from intravenous ...
dpaonthenet
5 天
Chemo hair loss device and sustainable weather sensor win James Dyson Awards
Inspired by her mother’s painful battle with cancer, Humphreys designed Athena – an affordable and portable device for ...
21 小时
on MSN
I was diagnosed with inoperable colon cancer, but eight years on I’m cancer free
My first meeting with the oncologist was the worst. I remember him saying, “You need to prepare yourself that this may not be ...
Vietnam Investment Reviev
2 小时
Innovent to Present Clinical Data of Multiple Novel Molecules at ESMO Asia 2024
Abstract Title: A single-arm, multicenter, Phase 2 study of hepatic arterial infusion chemotherapy (HAIC) combined with ...
2 天
on MSN
Teacher, 34, who revealed Stage 4 colon cancer on ‘Jeopardy!’ recalls his first symptoms
Christopher Burge was on 'Jeopardy!' on Nov. 19 and shared he has Stage 4 colon cancer at 34. He spoke with TODAY.com about ...
3 小时
Lung cancer is the leading cause of cancer deaths here in Florida. Here’s why
Floridians are at high risk for lung cancer, and many are waiting too long to get screened, which affects their survival rate ...
4 天
Colorado Man’s Lung Cancer Care With Immunotherapy
When Ed O. went to the ER for shortness of breath and trembling, he never imagined he’d receive a diagnosis of unresectable ...
BioSpace
5 天
Merck’s Subcutaneous Keytruda Meets Expectations in Phase III
Analysts are split on whether the positive trial results will help Merck stem future Keytruda losses as the mega-blockbuster ...
FiercePharma
5 天
Taking its best shot at Roche, Merck scores in phase 3 trial of subcutaneous Keytruda
On Tuesday, company revealed that its subcutaneous formulation of Keytruda has aced a phase 3 trial, demonstrating ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈